Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Arcadia Bio (RKDA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 28,330
  • Shares Outstanding, K 4,777
  • Annual Sales, $ 1,460 K
  • Annual Income, $ -13,480 K
  • 60-Month Beta -2.00
  • Price/Sales 19.61
  • Price/Cash Flow N/A
  • Price/Book 2.24

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.61
  • Number of Estimates 1
  • High Estimate -0.61
  • Low Estimate -0.61
  • Prior Year -4.86
  • Growth Rate Est. (year over year) +87.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.86 +1.21%
on 04/17/19
7.83 -24.27%
on 04/02/19
-1.36 (-18.66%)
since 03/18/19
3-Month
3.31 +79.15%
on 01/23/19
10.40 -42.98%
on 02/28/19
+2.27 (+62.02%)
since 01/18/19
52-Week
2.64 +124.20%
on 12/27/18
25.88 -77.09%
on 04/19/18
-19.79 (-76.94%)
since 04/18/18

Most Recent Stories

More News
Research Report Identifies Verso, Energous, Teekay Offshore Partners, Arcadia Biosciences, KVH Industries, and DHX Media with Renewed Outlook -- Fundamental Analysis, Calculating Forward Movement

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Verso Corporation (NYSE:VRS), Energous...

RKDA : 5.93 (-1.33%)
WATT : 5.08 (-2.31%)
TOO : 1.42 (-1.39%)
VRS : 21.71 (-0.82%)
DHXM : 1.50 (+1.14%)
VRSZQ : 0.0110 (-38.89%)
KVHI : 9.99 (+1.01%)
Cannabis Operations Span the Globe After Milestone Year

Throughout 2018, the cannabis market reached milestones and overcame thresholds, in one of the most important years for the industry ever. Notably, Canada's legalization of cannabis garnered many a headline....

RKDA : 5.93 (-1.33%)
CLSH : 0.3168 (-0.35%)
SPRWF : 1.4600 (-0.81%)
HEXO : 6.76 (+1.65%)
CLSH-U.CN : 0.310 (unch)
FIRE.TO : 1.94 (-0.51%)
TGOD.TO : 3.91 (-2.49%)
HEXO.TO : 8.99 (+1.58%)
TGODF : 2.9405 (-2.31%)
Arcadia Biosciences Welcomes Dr. Randy Shultz as Head of Research and Development

Arcadia Biosciences, Inc. (Nasdaq: RKDA), a food ingredient company and proven leader in agricultural innovation to improve the quality and nutritional content of crops, announced...

RKDA : 5.93 (-1.33%)
Regions Continue to Shift Towards CBD Legalization With Growing List of Medical Applications

The proliferation of cannabidiol, or CBD-based products, has exploded after U.S. President Donald Trump signed the Farm Bill in December 2018. Now, CBD products are appearing at supermarkets, health and...

RKDA : 5.93 (-1.33%)
EMHTF : 2.7744 (-2.31%)
CWBHF : 20.4495 (-2.21%)
CWEB.CN : 27.350 (-1.51%)
EMH.VN : 3.720 (-1.06%)
NLBS : 0.2020 (+1.25%)
NEPT.TO : 5.38 (+4.06%)
PBIO : 3.6550 (-3.82%)
NEPT : 4.03 (+4.13%)
Arcadia Biosciences: 4Q Earnings Snapshot

DAVIS, Calif. (AP) _ Arcadia Biosciences Inc. (RKDA) on Wednesday reported a loss of $646,000 in its fourth quarter.

RKDA : 5.93 (-1.33%)
Arcadia Biosciences Announces Fourth-Quarter and Full-Year 2018 Financial Results and Business Highlights

Arcadia Biosciences, Inc. (Nasdaq: RKDA), a food ingredient company and proven leader in agricultural innovation, improving the quality and nutritional content of crops, today released...

RKDA : 5.93 (-1.33%)
Arcadia Biosciences to Present at The Spring Investor Summit April 1-2, 2019

Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural food ingredient company and proven leader in improving the quality and nutritional content of crops, today announced that...

RKDA : 5.93 (-1.33%)
Verdeca Introduces HB4(R) Drought Tolerant Soybeans to Growers at Argentina's Expoagro

Verdeca, a joint venture between Arcadia Biosciences, Inc. (Nasdaq: RKDA) and Bioceres Crop Solutions Corp. (NYSE American: BIOX), introduced pre-commercial soybean varieties...

RKDA : 5.93 (-1.33%)
Regulatory Bodies Appraise Cannabis in a New Light With Industry Momentum Growing

Cannabis legalization has steadily become a trending topic among national governments over the course of recent years. The proliferation of countries moving to legalize cannabis on some form has also exponentially...

RKDA : 5.93 (-1.33%)
CLSH : 0.3168 (-0.35%)
NBEV : 5.27 (+0.19%)
ORHOF : 8.9741 (-1.10%)
CLSH-U.CN : 0.310 (unch)
OH.CN : 11.970 (-1.32%)
ZYNE : 8.09 (-1.70%)
Various Regions Begin to Examine Cannabis for Medicinal Designations

In the early twentieth century, cannabis was prohibited under the Marihuana Tax Act of 1937. Prior to that, cannabis was used as a medical remedy to treat maladies such as asthma, cough, migraine, insomnia,...

RKDA : 5.93 (-1.33%)
NBEV : 5.27 (+0.19%)
ITHUF : 5.1200 (+2.94%)
IAN.CN : 6.850 (+3.32%)
MLCPF : 3.5200 (+11.47%)
ZYNE : 8.09 (-1.70%)
LABS.VN : 5.180 (-0.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade RKDA with:

Business Summary

Arcadia Biosciences, Inc. is engaged in developing and commercializing agricultural products primarily in the United States. The Company's product includes nitrogen use crops, salt tolerant plants, sunflower oil and shelf-life produce. Arcadia Biosciences, Inc. is headquartered in Davis, California.

See More

Key Turning Points

2nd Resistance Point 6.30
1st Resistance Point 6.11
Last Price 5.93
1st Support Level 5.81
2nd Support Level 5.70

See More

52-Week High 25.88
Fibonacci 61.8% 17.00
Fibonacci 50% 14.26
Fibonacci 38.2% 11.52
Last Price 5.93
52-Week Low 2.64

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar